Important information

Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following and confirm your country of residence. Your confirmation must be true and accurate.


Artificial intelligence — the path towards a healthier world

DATA. DISCOVERY. DIAGNOSES.

The subscription period for Aiforia Technologies Plc’s initial public offering on the First North Growth Market was 29 November–8 December 2021. The final subscription price was EUR 5.01 per share in the institutional offering and in the public offering. Trading in Aiforias’s share commenced on the Nasdaq First North on 10 December. The ISIN code of the Shares is FI4000507934, and the trading code is AIFORIA.

About the initial public offering

Aiforia Technologies Plc aimed to raise gross proceeds approximately of EUR 27 million by offering a maximum of 5,393,657 new shares of the company for subscription. The number of new shares corresponds to approximately 21.3 per cent of the total number of Aiforia's shares after the offering assuming that the over-allotment option is not exercised. Assuming that the over-allotment option will be exercised in full, the offering consists of in total 5,992,459 Shares, corresponding to 23.1 per cent of the total number of shares after the offering.

The total number of Aiforia's shares after the offering will be 25,366,907 assuming that the over-allotment option is not exercised. Assuming that the over-allotment option will be exercised in full, the total number of Aiforia's shares will be 25,965,709.

Aiforia will receive gross proceeds of approximately EUR 30 million from the offering assuming that the over-allotment option will be exercised in full, and correspondingly approximately EUR 27 million assuming that the over-allotment option will not be exercised.

Dates of initial public offering

29 November 2021 The subscription period for the initial public offering commenced
8 December 2021 The subscription period for the public offering ended
9 December 2021 The final results of the initial public offering were announced
10 December 2021 The offer shares allocated in the public offering were recorded in the book-entry accounts of the investors
10 December 2021 Trading in the shares on the First North commenced

Subscription place of the shares

Nordnet Bank acts as the subscription place of the public offering through its online service at www.nordnet.fi/fi/aiforia.

Subscriptions can be made in the online service with bank identifiers of Nordnet, Aktia, Danske Bank, Handelsbanken, Nordea, Oma Säästöpankki, Osuuspankki, POP Pankki, S-Pankki, Säästöpankki and Ålandsbanken.

When submitting a commitment, the price to be paid for the offer shares in the public offering is the maximum price for the preliminary price range i.e. EUR 6.51 per offer share multiplied by the number of offer shares covered by the commitment.

Aiforia in brief

Aiforia is a Finnish company providing image analysis software utilising artificial intelligence (AI). The company’s business model is based on the development and utilisation of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics.

Software solutions offered by Aiforia are aimed at automating diagnostic analyses and the most laborious parts of image-based diagnostics by utilising deep learning AI models and cloud-based image management.

The company intends to use the net proceeds from the initial public offering to support the company's growth strategy predominantly in the following way: approximately 50% to sales and marketing, and approximately 50% to research and development as well as other operational purposes.

Aiforia’s strengths

Aiforia’s management believes that the following factors, in particular, are the company’s key strengths:

Existing AI technology and software solutions
Versatility VersatilityVersatilityVersatility
Cloud-based platform for managing, sharing and analysing large image files
Scalable business model
High-level competence of the management and personnel particularly in pathology and AI

Aiforia has customers using its software solutions across the world, with over 3,000 active users in over 50 countries and approximately
100 customer locations.